{"meta":{"ent":"amgen","name":"Amgen","kind":"company","hub":"earnings","sub":null,"tier":"T1","tier_review":null,"qa_rate":0.9944,"qa":{"n":14,"agree":14,"rate":1.0,"K":{"n":14,"agree":14,"rate":1.0}},"v":"K","symbol":"AMGN","next":{"date":"2027-02-02","ev":"k:KXEARNINGSMENTIONAMGN-27FEB02","by":null},"last":"2026-11-03","pending":null,"former":null,"url":"https://parrot.markets/earnings/AMGN","n_words":14,"note":"not advice: base rates, not forecasts; operators trade these markets (parrot.markets/disclosure); data CC BY 4.0, credit parrot.markets","license":"https://creativecommons.org/licenses/by/4.0/","as_of":"2026-11-11T21:14:30Z"},"cols":["w","key","n","y","rate","l10","tn","th"],"rows":[["Dazodalibep","dazodalibep",1,1,1.0,"Y",8,3],["Imfinzi / Durvalumab","durvalumab|imfinzi",1,1,1.0,"Y",8,2],["Eosinophilic","eosinophilic",1,1,1.0,"Y",8,6],["ESMO","esmo",1,1,1.0,"Y",8,2],["GLP-1 / GLP","glp|glp 1",1,1,1.0,"Y",8,6],["Medicare","medicare",1,1,1.0,"Y",8,2],["Acquisition","acquisition",1,0,0.0,"n",8,5],["Artificial Intelligence (3+ times)","artificial intelligence#3",1,0,0.0,"n",8,1],["Buyback / Buy Back","buy back|buyback",1,0,0.0,"n",8,0],["Litigation","litigation",1,0,0.0,"n",8,1]]}